Gram-Negative Bacterial Infections  >>  ciprofloxacin (Q3939)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT00910351: Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

Completed
1
19
US
Ciprofloxacin (Cipro, BAYQ3939)
Bayer
Pseudomonas Infection
10/10
10/10

Download Options